Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 24 Neoplasm Metastasis 7 Neoplasms 5 Prostate Cancer Metastatic 4 Carcinoma, Transitional Cell 4 Recurrence 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Solid Cancer 1 Small Cell Lung Carcinoma 1 Penile Neoplasms 1 Ovarian Neoplasms 1 Nonseminomatous germ cell tumor 1 Neoplastic Cells, Circulating 1 Metastatic Castration-resistant Prostate Cancer 1 Malignant Solid Tumor - Malignant Nervous System Neoplasm 1 Lymphadenopathy 1 Liposarcoma 1 Hormone Refractory Prostate Cancer 1 Head and Neck Neoplasms 1 Glioblastoma 1 Breast Neoplasms 1 Bone Metastatic Prostate Cancer 1 Advanced Solid Tumor 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bone Metastatic Prostate Cancer × cabazitaxel × Clear all

NCT02512458 2020-02-10

CABA-BONE

Hellenic Cooperative Oncology Group

Phase 2 Completed

Bone Metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡